Literature DB >> 17661520

Biosynthesis of unusual aminocyclitol-containing natural products.

Taifo Mahmud1, Patricia M Flatt, Xiumei Wu.   

Abstract

The aminocyclitol family of natural products is a class of sugar-derived microbial secondary metabolites that demonstrate significant biological activities. Within this class of natural products are the C7N-aminocyclitol-containing compounds, which were originally associated with potent sugar-hydrolase inhibition. However, recent discoveries indicate a broader array of chemical structures and biological activities of this class of compounds. Using both conventional feeding experiments and contemporary molecular genetic approaches, some progress has been made in understanding the biosynthesis of this class of natural products. Results of in silico investigation also suggest a wide distribution of this class of natural products or closely related compounds across different classes of microorganisms, including cyanobacteria and fungi. This review describes our recent progress in the biosynthetic studies of a number of C7N-aminocyclitol-containing compounds and the potential use of bioinformatic approaches to search for novel aminocyclitol-containing natural products.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17661520      PMCID: PMC2527543          DOI: 10.1021/np070210q

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  30 in total

1.  BE-40644, a new human thioredoxin system inhibitor isolated from Actinoplanes sp. A40644.

Authors:  K Torigoe; N Wakasugi; N Sakaizumi; T Ikejima; H Suzuki; K Kojiri; H Suda
Journal:  J Antibiot (Tokyo)       Date:  1996-03       Impact factor: 2.649

2.  Epoxyquinomicins A and B, new antibiotics from Amycolatopsis.

Authors:  T Tsuchida; M Umekita; N Kinoshita; H Iinuma; H Nakamura; K Nakamura; H Naganawa; T Sawa; M Hamada; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1996-03       Impact factor: 2.649

3.  Studies on validamycins, new antibiotics. IV. Isolation and characterizatin of validamycins A and B.

Authors:  T Iwasa; Y Kameda; M Asai; S Horii; K Mizuno
Journal:  J Antibiot (Tokyo)       Date:  1971-02       Impact factor: 2.649

Review 4.  Natural products derived from unusual variants of the shikimate pathway.

Authors:  H G Floss
Journal:  Nat Prod Rep       Date:  1997-10       Impact factor: 13.423

5.  Pyralomicins, novel antibiotics from Microtetraspora spiralis. III. Biosynthesis of pyralomicin 1a.

Authors:  N Kawamura; R Sawa; Y Takahashi; T Sawa; H Naganawa; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1996-07       Impact factor: 2.649

6.  Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp.

Authors:  M Bierman; R Logan; K O'Brien; E T Seno; R N Rao; B E Schoner
Journal:  Gene       Date:  1992-07-01       Impact factor: 3.688

Review 7.  Aminoglycoside antibiotics in infectious diseases. An overview.

Authors:  W E Siegenthaler; A Bonetti; R Luthy
Journal:  Am J Med       Date:  1986-06-30       Impact factor: 4.965

8.  A relationship between the mevalonate pathway and isoprenoid production in actinomycetes.

Authors:  Takashi Kawasaki; Tomohisa Kuzuyama; Kazuo Furihata; Nobuya Itoh; Haruo Seto; Tohru Dairi
Journal:  J Antibiot (Tokyo)       Date:  2003-11       Impact factor: 2.649

9.  Pyralomicins, novel antibiotics from Microtetraspora spiralis. II. Structure determination.

Authors:  N Kawamura; R Sawa; Y Takahashi; K Isshiki; T Sawa; H Naganawa; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1996-07       Impact factor: 2.649

10.  Effect of validamycins on glycohydrolases of Rhizoctonia solani.

Authors:  N Asano; T Yamaguchi; Y Kameda; K Matsui
Journal:  J Antibiot (Tokyo)       Date:  1987-04       Impact factor: 2.649

View more
  11 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

2.  The genetic and molecular basis for sunscreen biosynthesis in cyanobacteria.

Authors:  Emily P Balskus; Christopher T Walsh
Journal:  Science       Date:  2010-09-02       Impact factor: 47.728

3.  Complete biosynthetic pathway to the antidiabetic drug acarbose.

Authors:  Takeshi Tsunoda; Arash Samadi; Sachin Burade; Taifo Mahmud
Journal:  Nat Commun       Date:  2022-06-15       Impact factor: 17.694

4.  Genetically engineered production of 1,1'-bis-valienamine and validienamycin in Streptomyces hygroscopicus and their conversion to valienamine.

Authors:  Hui Xu; Jongtae Yang; Linquan Bai; Zixin Deng; Taifo Mahmud
Journal:  Appl Microbiol Biotechnol       Date:  2008-09-27       Impact factor: 4.813

5.  Evolution and Distribution of C7-Cyclitol Synthases in Prokaryotes and Eukaryotes.

Authors:  Andrew R Osborn; Kelsey M Kean; Khaled M Alseud; Khaled H Almabruk; Shumpei Asamizu; Janet A Lee; P Andrew Karplus; Taifo Mahmud
Journal:  ACS Chem Biol       Date:  2017-02-17       Impact factor: 5.100

Review 6.  Progress in aminocyclitol biosynthesis.

Authors:  Taifo Mahmud
Journal:  Curr Opin Chem Biol       Date:  2009-03-25       Impact factor: 8.822

7.  Asymmetric stereodivergent strategy towards aminocyclitols.

Authors:  Barry M Trost; Sushant Malhotra
Journal:  Chemistry       Date:  2014-05-28       Impact factor: 5.236

Review 8.  Bioactive oligosaccharide natural products.

Authors:  Emilianne K McCranie; Brian O Bachmann
Journal:  Nat Prod Rep       Date:  2014-08       Impact factor: 13.423

9.  Mechanistic insights into validoxylamine A 7'-phosphate synthesis by VldE using the structure of the entire product complex.

Authors:  Michael C Cavalier; Young-Sun Yim; Shumpei Asamizu; David Neau; Khaled H Almabruk; Taifo Mahmud; Yong-Hwan Lee
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

10.  Modulation of Specialized Metabolite Production in Genetically Engineered Streptomyces pactum.

Authors:  Zhiran Ju; Wei Zhou; Hattan A Alharbi; Daniel C Howell; Taifo Mahmud
Journal:  ACS Chem Biol       Date:  2021-11-01       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.